Actual use of PROMs in Asthma and Rhinitis recommended by guidelines in
clinical settings: PROMUSE Respiratory Study
Abstract
Background: Guidelines advise for the implementation of patient-reported
outcomes (PROMs). Our objective is to identify the utilization patterns
of PROMs, together with the reasons for their usage and the barriers to
their adoption among practitioners managing patients with asthma,
allergic rhinitis (AR), and rhinosinusitis (RS). Methods: This was a
cross-sectional observational study using a questionnaire encompassing
all pertinent PROMs and disseminated to practitioners associated with
the ARIA, UCARE, ADCARE, and ACARE networks. Individuals unfamiliar with
PROMS or lacking prior experience with it were eliminated. Descriptive
and analytical data were utilized, categorized by the frequency and type
of PROMs applied. Stata 18.0 was utilized, with p<0.05
indicating statistical significance. Results: A total of 439
practitioners participated, with PROMs predominantly utilized by
physicians certified for over 30 years and by respiratory specialists
(16.67% and 12.46%, respectively; p<0.05). Pulmonologists
exhibited the greatest utilization of asthma PROMs at 86%, while
allergists predominantly employed AR and RS PROMs at 38.42% and
33.33%, respectively (p < 0.001). ACT (66.74%), RCAT
(27.79%), and SNOTT22 (15.26%) were the predominant PROMs utilized
primarily for asthma (79.19%), AR (51.23%), and RS (57.26%),
respectively (p<0.001). The foremost purposes for their
application were disease control monitoring (93.39%) and evaluation of
performance of therapy approaches (90.2%). The most significant barrier
identified was time constraint, rated at 75.40% (p>0.05
across all groups). Conclusions: The use of PROMs is suboptimal,
primarily due to time limitations. It is imperative that methods be
swiftly implemented to include these techniques into the therapeutic
environment to attain enhanced outcomes.